Stock Information
Organon & Co (OGN)
Ticker Symbol: OGN
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $1,798.78 mil
Piotroski score: 5
PE Ratio: 12.8209
EPS (TTM): 0.7166
Revenue (TTM): $23.89 M
Dividend Yield: 0.8686210640608%
ROE: 25.5%
Latest News
-
Reported Earlier: 'Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon' - Bloomberg
Thu, Apr 16, 2026 9:27 AM
-
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026
Thu, Apr 16, 2026 7:32 AM
-
Why Organon (OGN) Is Surging as Buyout Interest Gains Traction
Thu, Apr 16, 2026 7:27 AM
-
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
Wed, Apr 15, 2026 11:30 AM
-
Organon Says VTAMA Creamwas Granted Strong, Evidence-Based Recommendation By AAD In 2026 Guidelines For Management And Treatment Of AD In Pediatric Patients, Published On April 7
Wed, Apr 15, 2026 7:36 AM
-
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note
Mon, Apr 13, 2026 10:00 PM
-
Organon Takeover At $15? Probably Not, Here's Why
Mon, Apr 13, 2026 7:30 AM
-
Dow Dips Over 250 Points: Investor Sentiment Declines, Greed Index Remains In 'Fear' Zone
Mon, Apr 13, 2026 2:42 AM
-
Is Organon (OGN) Now An Opportunity After Its Recent Share Price Surge?
Mon, Apr 13, 2026 1:11 AM
-
Organon (OGN) Climbs 39% on $12-Billion Merger Buzz
Sat, Apr 11, 2026 10:05 PM
Key Financials
Financial data not available